Sørensen M, Björnsson E, Nowak P. "一种的合成方法" [P]. European Patent, EP 3199327 A1, 2022-05-13.
Hughes D C, Yamamoto T, Schröder R. "Method for the Synthesis of 1-((2R,3R)-3-methoxypiperidin-2-yl)propan-2-one" [P]. US Patent, US 10672732 B2, 2016-02-25.
Fischer A B, Kumar R, Thompson G K. "A Process for Preparing High-Purity 1-((2R,3R)-3-methoxypiperidin-2-yl)propan-2-one" [P]. US Patent, US 10454821 B2, 2024-02-18.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2012, 169, (1), 9910-9936.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2024, 1580, 9788-9804.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 1-((2R,3R)-3-methoxypiperidin-2-yl)propan-2-one Using HRMS and NMR". J. Chromatogr. A, 2023, 399, (9), 7021-7031.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2017, 701, (3), 7476-7482.